Agenus
AGEN
#8288
Rank
NZ$0.55 B
Marketcap
NZ$13.34
Share price
4.27%
Change (1 day)
46.10%
Change (1 year)

Earnings for Agenus (AGEN)

Earnings in 2026 (TTM): NZ$0.20 Billion

According to Agenus 's latest financial reports the company's current earnings are NZ$0.12 Billion. In 2025 the company made an earning of NZ$89.02 Million, an increase over its 2024 earnings that were of -NZ$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agenus from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.20 B134.17%
2025 NZ$89.02 M-145.52%
2024 -NZ$0.2 Billion-28.13%
2023 -NZ$0.28 Billion-5.5%
2022 -NZ$0.29 Billion-556.26%
2021 NZ$63.1 M-130.37%
2020 -NZ$0.21 Billion73.75%
2019 -NZ$0.12 Billion-48.74%
2018 -NZ$0.24 Billion34.32%
2017 -NZ$0.18 Billion-7.16%
2016 -NZ$0.19 Billion26.55%
2015 -NZ$0.15 Billion110.24%
2014 -NZ$70.33 Million49.12%
2013 -NZ$47.16 Million
2011 -NZ$32.56 Million-12.25%
2010 -NZ$37.11 Million-21.41%
2009 -NZ$47.22 Million-26.86%
2008 -NZ$64.56 Million13.72%
2007 -NZ$56.77 Million-33.4%
2006 -NZ$85.24 Million-31.84%
2005 -NZ$0.13 Billion9.74%
2004 -NZ$0.12 Billion-0.8%
2003 -NZ$0.12 Billion17.37%
2002 -NZ$97.87 Million37.83%
2001 -NZ$71.01 Million55.99%
2000 -NZ$45.52 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$44.31 B 21,614.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$22.43 B 10,892.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.37 B 7,921.56%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$17.07 B 8,267.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-NZ$0.53 Billion-358.33%๐Ÿ‡บ๐Ÿ‡ธ USA